Globe Life opened higher at $163.67, compared with its previous close of $161.80. In the last trading session, the stock traded between $159.68 and $163.67. It showed a downward intraday trend.
Return calculator
Time Period
An investment of $100 made 5 years ago in Globe Life is now worth
$ 171.50
Giving a profit of
$ 71.50 (71.50%)
Invest with $1
Note: Past profits do not guarantee future returns.
Analyst Overview
Rating from 6 Analysts
Buy
83.33%
Hold
16.67%
Sell
0%
Markets Today
Today's Change
$-1.70 (-1.05%)
Day High
$163.67
Day Low
$159.68
Day Open
$163.67
Prev Close
$161.80
Volume
1,72,501
1W Return
-1.00%
1M Return
-3.09%
3M Return
-11.60%
6M Return
4.05%
1Y Return
21.00%
Fundamentals
Market Cap ($ Mn)
12,078
PE Ratio
11.47
PB Ratio
2.16
PEG Ratio
0.73
ROE
20.88%
ROCE
-
EPS (TTM)
$4.75
Investment Returns
1 Week
-1.00%
1 Month
-3.09%
3 Months
-11.60%
6 Months
4.05%
9 Months
11.23%
Financials
Quarterly
All values in $ Mn
1.5K
Mar 25
1.5K
Jun 25
1.5K
Sep 25
1.5K
Dec 25
1.6K
Jun 26
1.6K
Sep 26
Updates
22Oct
Globe Life FY26 guidance cut to $15.35-$15.65, misses estimates
Globe Life lowers FY26 adjusted EPS guidance to $15.35-$15.65. New guidance range is below the previous forecast of $15.55-$15.95. Revised outlook misses the analyst estimate of $15.71.
22 days ago
22Oct
Globe Life Q3 Results: Sales up 5.49% YoY to $1.596 billion
Quarterly sales rose 5.49% YoY to $1.596 billion, beating estimates by 3.76%. Adjusted EPS of $4.84 missed the consensus estimate of $4.88 by 0.82%. EPS growth of 0.62% YoY significantly trailed the 5.49% revenue expansion.
22 days ago
22Oct
Globe Life guides FY27 adj EPS of $16.10-$17.10 vs $16.50 est
Globe Life guides adjusted EPS of $16.10 to $17.10 for FY27. Analyst consensus estimate stands at $16.50. Guidance range spans $1.00 with midpoint near market expectations.
22 days ago
15Oct
JP Morgan raises Globe Life price target to $195, keeps overweight
JP Morgan raised Globe Life's price target from $193 to $195. Analyst Pablo Singzon maintained an Overweight rating on the stock. The price target increase represents a $2 uplift in valuation.
28 days ago
5Oct
Morgan Stanley lowers Globe Life price target to $197, keeps Overweight
Morgan Stanley lowers Globe Life price target to $197 from $208. Analyst Bob Huang maintains an Overweight rating on the stock. The price target reduction amounts to an $11 decrease.
1mo ago
10Aug
Globe Life Inc authorizes $2.5 billion share buyback program
Globe Life Inc. secured Board approval for a $2.5 billion share repurchase authorization effective August 15, 2026. Replacing prior limits, the program highlights the company’s strong free cash flow generation and disciplined capital allocation. Co-CEOs Matt Darden and Frank Svoboda reaffirmed their commitment to maximizing shareholder value, noting nearly $11.5 billion returned since 1986.
